Buy LAMADOL 50mg|ml Injection 5x2ml Online At Best Price In Pakistan

Dosage

Missed Dose

Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low.

Overdose

Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very less. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.

Interactions

Amitriptyline

Fluoxetine

Ketoconazole

Ofloxacin

Warfarin

Codeine

Theophylline

Monoamine

Prescribes

Moderate to severe pain

This medicine is used to relieve moderate to severe pain in patients who require an opioid analgesic and for which alternative treatments are inadequate. It also helps to relieve cancer pain and postoperative pain.

Side Effects

Constipation  

Pain at the injection site  

Dizziness  

Sense of imbalance  

Headache  

Sleepiness  

Agitation and anxiety  

Indigestion  

Convulsions   (rare)

Irregular heartbeat  

Shortness of breath  

Itching or rash  

Nervousness  

Warnings

Drug dependence and abuse

Respiratory disorders

Hypotension

Reduced fertility

Acute abdominal conditions

Suicidal tendencies

Elderly patients

Use in children

Withdrawal symptoms

Driving or operating machinery

Pregnancy

Breast-feeding

When Not To Use

Allergy

This medicine is not recommended for use in patients with a known allergy to LAMADOL 50mg|ml Injection 5x2ml or any other inactive ingredients present in the formulation.

Severe asthma and breathing problems

This medicine is not recommended for use in patients suffering from breathing difficulties which may be caused due to various conditions such as asthma, hypercapnia, etc. since it may worsen the patient's condition.

Gastrointestinal bleeding

This medicine is not recommended for use in patients with a known history of gastrointestinal bleeding due to the increased risk of worsening of the patient's condition.

Monoamine oxidase inhibitors

This medicine is not recommended for use in patients taking monoamine oxidase inhibitors (MAOI) due to the increased risk of serious and life-threatening side effects. A time gap of at least 14 days should be maintained between stopping therapy with MAOIs and starting therapy with this medicine.

Gastrointestinal obstruction

This medicine is not recommended for use in patients with gastrointestinal obstruction including paralytic ileus due to the increased risk of worsening of the patient's condition.